NFKB1 and plasma cell myeloma: Although more evidence is needed to delineate the role of NF-kB in the celastrol-mediated myeloma regression, the current study reveals that celastrol inhibits multiple NF-kB-driven protein expression that is involved in myeloma proliferation.